Back to News and Publications
See media contact
View media kit

A screen of repurposed drugs identifies AMHR2/MISR2 agonists as potential contraceptives

35 mins to read
April 5, 2022

We want to hear from you.

Contact Us
Oviva Therapeutics, Inc. is a Cambrian BioPharma, Inc PipeCo
© 2022 Oviva Therapeutics, Inc. All rights reserved.
>